Clinical Trials Logo

Clinical Trial Summary

The research study is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in hepatic lipid accumulation, visceral adipose tissue and postprandial lipid, markers of inflammation and energy metabolism in participants who consume 3 study foods per day for 16 week, while maintaining their body weight.

Clinical Trial Description

The study objectives include: 1. To determine the impact of dietary soybean oil on ectopic liver fat and visceral adipose in adults with nonalcoholic fatty liver disease (NAFLD) or similar diagnosis 2. To evaluate the effect of soybean oil supplementation on postprandial lipids, markers of inflammation and energy metabolism 3. To measure the strength of the association of change in plasma linoleic acid with changes in ectopic liver fat, visceral adipose, and postprandial lipids, markers of inflammation and energy metabolism 4. To explore emerging mechanistic targets of LA-rich soybean oils that are linked with reduced liver fat and better cardiometabolic health ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05199948
Study type Interventional
Source Ohio State University
Status Active, not recruiting
Phase N/A
Start date May 2, 2022
Completion date February 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT04031729 - Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease Phase 1/Phase 2
Recruiting NCT03725631 - Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD N/A
Active, not recruiting NCT05084404 - Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease Phase 2
Completed NCT05081427 - Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2
Recruiting NCT05430178 - Metabolic Pathology of Pediatric NAFLD N/A
Recruiting NCT04389593 - Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference
Active, not recruiting NCT03696797 - Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease N/A
Terminated NCT02365233 - Fatty Liver Study in Patients With Type II Diabetes Phase 4
Completed NCT05309642 - Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study N/A
Completed NCT03763877 - A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD Phase 2
Completed NCT04828551 - Noninvasive Biomarkers of Metabolic Liver Disease 1.1 N/A
Completed NCT05792423 - Conditionally Increased Output (CIO) Enhanced Ultrasound System N/A
Not yet recruiting NCT06335771 - Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity N/A
Recruiting NCT02815891 - A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Not yet recruiting NCT05908877 - Cardio-Metabolic Risk Evaluation in Overweight and Obese Children
Not yet recruiting NCT04887766 - Study on GS300 on NAFLD N/A
Completed NCT03986684 - Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease
Recruiting NCT05165706 - Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance N/A
Completed NCT04235205 - Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease Phase 2
Recruiting NCT05680233 - Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis Phase 1